Skip to content
DataLookout
Menu

MEND-PNPONCT04706013

Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency

StatusActive, Not Recruiting
PhasePhase 3
SponsorMedicure
Primary completion (estimated)

At risk: Primary completion moved at least 9 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 12 versions: 11 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Minor Trial sites expanded: 7 → 10 locations
  2. Notable Primary and study completion pushed from Nov 2026 to Sep 2027
    • Eligibility criteria expanded, about 6 words
    • Enrollment closed, study ongoing
    • Site details revised at 7 of 7 sites
  3. Notable Eligibility criteria expanded, about 5 words
    • Study sites: 6 to 7
    v10
  4. Notable Primary and study completion dates: May 2025 to Nov 2026v8
  5. Minor Study sites: 5 to 6v7
Show 5 earlier versionsHide 5 earlier versions
  1. Minor Study sites: 2 to 5v6
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 1 to 2
    • Primary completion date: Feb 2025 to May 2025
    • Start date changed from estimate of Jan 2024 to Feb 16, 2024
    v5
  3. Notable Primary completion date: Nov 2023 to Feb 2025
    • Start date: Oct 2022 to Jan 2024
    • Study sites: 0 to 1
    • Study completion date: Nov 2023 to May 2025
    v4
  4. Notable Primary and study completion dates: Nov 2022 to Nov 2023
    • Start date: Oct 2021 to Oct 2022
    v3
  5. Notable Primary and study completion dates: Apr 2022 to Nov 2022
    • Start date: Mar 2021 to Oct 2021
    v2
  1. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Overall survival time (time to death), including incidence of death at 12 months
Timeframe: 12 months

Secondary (1)

Frequency of seizures (including but not limited to status epilepticus)

Arms and interventions

Single Arm ActiveExperimental

Pyridoxal 5'-Phosphate

Drugs: Pyridoxal Phosphate

Sites

10 sites in 3 countries

United States 6, Poland 3, Australia 1